{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-001035","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2022-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.931217+00:00","generated_at":"2026-06-27T08:49:20.714747+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Gen. H.R. McMaster to retire from NRX Pharmaceuticals Board at next annual meeting","bullets":["Gen. McMaster informed the Board on Feb 7, 2022 that he will retire effective the next Annual Meeting.","His term would have expired in 2024; he will continue as director until the Annual Meeting.","No disagreement with the Company cited; McMaster will remain as an advisor.","Board thanked McMaster for service; company developing NRX-101 for suicidal depression and PTSD."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-001035","json":"https://secwatch.observer/filing/0001558370-22-001035.json","markdown":"https://secwatch.observer/filing/0001558370-22-001035.md","text":"https://secwatch.observer/filing/0001558370-22-001035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/0001558370-22-001035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/nrxp-20220211x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:49:20.714747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7798c0db30","claim":"Gen. H.R. McMaster departed as director at NRX Pharmaceuticals, Inc..","evidence_excerpt":"On February 7, 2022, one of the Company’s directors Gen. H.R. McMaster informed the Board that he would be retiring from the Board with effect from the next Annual Meeting of Shareholders (the “Annual Meeting”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1719406/000155837022001035/0001558370-22-001035-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retiring"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}